Announced Thu, 25 Jun · 19:33 IST
Vivimed Labs clarifies NSE queries on FY25 results filing
Regulatory & Legal View source PDF
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.8%1-day move
₹5.70
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+1.8+0.9+1.8+1.6-0.9-6.0-7.0———
Up moveDown movePending
AI summary
Vivimed Labs answered NSE queries on FY25 results. Board meeting ended 22:10 PM on 30 May 2025; results uploaded next day at 12:13 PM, citing scanner problems. MD/CEO sign missing - Whole Time Director signed instead. XBRL errors unresolved. Auditor gave qualified opinion: company did not record Rs. 574.44 million interest, bank borrowings of Rs. 3,744.56 million unconfirmed, all loans NPA. Standalone net loss Rs. 314.96 million.
Likely market impact
NPA loans, defaulted bank repayments, and audit qualifications flag serious financial distress. Negative net worth on consolidated adjusted basis.